Prestige Wealth Management Group’s CONMED CNMD Stock Holding History

Prestige Wealth Management Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6	Closed	-$412	–	1020
2024 Q4	$412	Hold	6	–	–	﹤0.01%	989
2024 Q3	$433	Sell	6 -4	-40%	-$282	﹤0.01%	983
2024 Q2	$696	Sell	10 -3	-23%	-$219	﹤0.01%	887
2024 Q1	$1.04K	Hold	13	–	–	﹤0.01%	860
2023 Q4	$1.43K	Buy	13 +3	+30%	+$310	﹤0.01%	819
2023 Q3	$1.01K	Hold	10	–	–	﹤0.01%	882
2023 Q2	$1.36K	Hold	10	–	–	﹤0.01%	850
2023 Q1	$1.04K	Hold	10	–	–	﹤0.01%	887
2022 Q4	$888	Buy	+10	New	+$830	﹤0.01%	994
2022 Q3	–	Sell	-12	Closed	-$1K	–	978
2022 Q2	$1K	Buy	+12	New	+$1.44K	﹤0.01%	831
2020 Q2	–	Sell	-6	Closed	–	–	892
2020 Q1	$0	Buy	+6	New	+$553	﹤0.01%	917

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Prestige Wealth Management Group's CNMD Position: Q1 2025 in Review

Prestige Wealth Management Group sold out of CONMED (CNMD) in Q1 2025, closing a stake of 6 shares — an estimated $412 sold.

Prestige Wealth Management Group first reported a position in CNMD in Q1 2020 and held it in 11 quarters. The position peaked at $1.43K in Q4 2023. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

Prestige Wealth Management Group reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
Prestige Wealth Management Group sold 6 CONMED shares in Q1 2025, an estimated $412.
Prestige Wealth Management Group first reported a position in CONMED in Q1 2020 and held it in 11 quarters.
Prestige Wealth Management Group's CONMED position peaked at $1.43K in Q4 2023.
280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Prestige Wealth Management Group's 13F filing for Q1 2025, filed 12 May 2025.